Satoshi Setoguchi

Director/Miembro de la Junta en ASTENA HOLDINGS CO., LTD. .

Fortuna: 212 385 $ al 31/05/2024

52 años

Health Technology

Retail Trade

Perfil

Satoshi Setoguchi is currently working as the President, CEO, Chief Operating Officer & Director at Iwaki & Co., Ltd.
He is also serving as the Director & Managing Executive Officer at Astena Holdings Co., Ltd.
since 2020 and as a Director at Apros Corp.
since 2015.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
ASTENA HOLDINGS CO.,LTD. 0.17%	30/11/2023	69 100 ( 0.17% )	212 385 $	31/05/2024

Cargos activos de Satoshi Setoguchi

Empresas	Cargo	Inicio
ASTENA HOLDINGS CO., LTD.	Director/Miembro de la Junta	01/02/2019
Apros Corp.	Director/Miembro de la Junta	01/12/2015
Iwaki & Co., Ltd. Iwaki & Co., Ltd. Drugstore ChainsRetail Trade Part of Astena Holdings Co., Ltd., Iwaki & Co., Ltd. is a bio development group that offers a wide range of services including drug discovery screening kits, ELISA kits, antibody reagents, antibody-produced services, and drugs for in vitro diagnosis and related products. Iwaki & Co. is based in Tokyo, JP. The Japanese company also provides planning, development, and sales support for commercialization of researchers' latest technology from overseas/domestic venture companies. The company was founded in 2020, and the CEO is Satoshi Setoguchi.	Director Ejecutivo	-

Todos los cargos activos de Satoshi Setoguchi

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Satoshi Setoguchi.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
ASTENA HOLDINGS CO., LTD.	Health Technology

Empresas privadas	2
Apros Corp.
Iwaki & Co., Ltd. Iwaki & Co., Ltd. Drugstore ChainsRetail Trade Part of Astena Holdings Co., Ltd., Iwaki & Co., Ltd. is a bio development group that offers a wide range of services including drug discovery screening kits, ELISA kits, antibody reagents, antibody-produced services, and drugs for in vitro diagnosis and related products. Iwaki & Co. is based in Tokyo, JP. The Japanese company also provides planning, development, and sales support for commercialization of researchers' latest technology from overseas/domestic venture companies. The company was founded in 2020, and the CEO is Satoshi Setoguchi.	Retail Trade